Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: an AGEO European Cohort - Vigipallia

0 avis

Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: an AGEO European Cohort

Archive ouverte

Taïeb, Julien | Sayah, Lina | Heinrich, Kathrin | Kunzmann, Volker | Boileve, Alice | Cirkel, Geert | Lonardi, Sara | Chibaudel, Benoist | Turpin, Anthony | Beller, Tamar | Hautefeuille, Vincent | Vivaldi, Caterina | Mazard, Thibault | Bauguion, Lucile | Niger, Monica | Prager, Gerald | Coutzac, Clelia | Benedikt Westphalen, C. | Auclin, Edouard | Pilla, Lorenzo

Edité par CCSD ; Elsevier -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study

Archive ouverte | Flecchia, Clémence | CCSD

International audience

Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies

Archive ouverte | Parisi, Alessandro | CCSD

International audience

Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial

Archive ouverte | Conroy, Thierry | CCSD

Chargement des enrichissements...